Arkolith/Insider Trading/TRDA/Form 4

Dowden Nathan J

President & COOEntrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed May 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$230K
Net Open-Market Flow
-$230K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)15K$1.74$26K214K
May 4, 2026Sell(S)15K$15.33$230K199K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)15K—$050K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001873392-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML